1. Effect of maraviroc on non-R5 tropic HIV-1: refined analysis of subjects from the phase IIb study A4001029. (January 2015) Authors: Surdo, M.; Alteri, C.; Puertas, M.C.; Saccomandi, P.; Parrotta, L.; Swenson, L.; Chapman, D.; Costa, G.; Artese, A.; Balestra, E.; Aquaro, S.; Alcaro, S.; Lewis, M.; Clotet, B.; Harrigan, R.; Valdez, H.; Svicher, V.; Perno, C.F.; Martinez-Picado, J.; Ceccherini-Silberstein, F. Journal: Clinical microbiology and infection Issue: Volume 21:Number 1(2015:Jan.) Page Start: 103.e1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. PB1779: DEVELOPING NOVEL SYNERGISTIC DRUG COMBINATIONS WITH VENETOCLAX IN ACUTE MYELOID LEUKAEMIA. (23rd June 2022) Authors: Harrigan, R.; Johnston, E.; Matchett, K.; Bjourson, T. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 1659 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗